Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             144 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrant methylation of CpG island as a mechanism for inactivation of tumor suppressor genes 1994
 11 S2 p. 159-160
2 p.
 artikel
2 A data-based meta-analysis of randomised trials of chemotherapy versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC) Souhami, R.L.
 1994
 11 S2 p. 24-25
2 p.
 artikel
3 Adenoma-carcinoma sequence in non-mucus producing bronchioloalveolar carcinoma of the lung 1994
 11 S2 p. 98-99
2 p.
 artikel
4 Adjuvant radiotherapy on operable (stages I-IIIA) non-small cell lung cancer (NSCLC) 1994
 11 S2 p. 45-46
2 p.
 artikel
5 Adjuvant therapy for stage I, II and resectable IIIA disease-the North American experience 1994
 11 S2 p. 47-48
2 p.
 artikel
6 Advances in the detection of preneoplasia and early carcinoma: Opening remarks to mini-symposia 1994
 11 S2 p. 13-15
3 p.
 artikel
7 A meta-analysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) using updated individual patient data 1994
 11 S2 p. 49-50
2 p.
 artikel
8 Anti-CEA monoclonal antibody scintigraphies in lung cancer Buccheri, Gianfranco
 1994
 11 S2 p. 86-87
2 p.
 artikel
9 Antioxidants in the chemoprevention of lung cancer 1994
 11 S2 p. 96-97
2 p.
 artikel
10 A phase III study of VP16 plus cisplatin (VP) alone or with ifosfamide (VIP) in previously untreated patients (pts) with extensive small cell carcinoma of the lung (SCLC): A hoosier oncology group trial 1994
 11 S2 p. 242-
1 p.
 artikel
11 A phase II trial of paclitaxel in previously untreated patients with extensive-stage small cell lung cancer (SCLC) 1994
 11 S2 p. 234-
1 p.
 artikel
12 A randomized study of chest x-ray screening for lung cancer as part of the prostate, lung, colorectal, and ovarian (PLCO) trial 1994
 11 S2 p. 82-83
2 p.
 artikel
13 A review of current investigations regarding the biology of pleural mesothelioma 1994
 11 S2 p. 219-220
2 p.
 artikel
14 Bcl-2 protein in non-small-cell lung carcinoma. Immunohistochemical evidence of abnormal expression and correlation with survival 1994
 11 S2 p. 104-105
2 p.
 artikel
15 Biological implications of neuroendocrine gene expression in fetal lung development 1994
 11 S2 p. 195-196
2 p.
 artikel
16 Biological significance of altered carbohydrate antigen expression in non-small cell lung cancer 1994
 11 S2 p. 120-121
2 p.
 artikel
17 Biology of small cell lung cancer 1994
 11 S2 p. 227-
1 p.
 artikel
18 Bombesin-like peptides in pulmonary diseases and lung cancer 1994
 11 S2 p. 211-212
2 p.
 artikel
19 Bombesin receptor regulation of signal transduction pathways and the control of cell growth 1994
 11 S2 p. 11-12
2 p.
 artikel
20 Cell kinetics in non-small cell carcinoma of the lung 1994
 11 S2 p. 112-113
2 p.
 artikel
21 Chart in non-small cell carcinoma of the lung 1994
 11 S2 p. 51-52
2 p.
 artikel
22 Chemotherapy for stage III non-small cell lung cancer 1994
 11 S2 p. 148-150
3 p.
 artikel
23 Chemotherapy for the elderly or unfit patient with small cell lung cancer 1994
 11 S2 p. 140-141
2 p.
 artikel
24 Chronic cancer pain management: Current controversies in treatment 1994
 11 S2 p. 254-255
2 p.
 artikel
25 Classification of neuroendocrine tumors of the lung Travis, William D.
 1994
 11 S2 p. 197-198
2 p.
 artikel
26 Clinical development of irinotecan (CPT-11) in lung cancers 1994
 11 S2 p. 30-31
2 p.
 artikel
27 Clinical reversal of drug resistance 1994
 11 S2 p. 207-208
2 p.
 artikel
28 Combined-modality therapy in non-small cell lung cancer 1994
 11 S2 p. 245-
1 p.
 artikel
29 Combined modality therapy of small-cell lung cancer 1994
 11 S2 p. 179-180
2 p.
 artikel
30 Combined modality treatment of mesothelioma 1994
 11 S2 p. 217-218
2 p.
 artikel
31 Combined modality treatment of small cell carcinoma of the bronchus (SCLC) - The EORTC LCCG experience Gregor, A.
 1994
 11 S2 p. 175-176
2 p.
 artikel
32 Combined radio-chemotherapy in the management of locally advanced non-small cell lung cancer (NSCLC) 1994
 11 S2 p. 146-147
2 p.
 artikel
33 Comparison of immune and molecular targets for early lung cancer detection 1994
 11 S2 p. 167-168
2 p.
 artikel
34 Control of the G1/S phase transition 1994
 11 S2 p. 10-
1 p.
 artikel
35 Controversies in diagnosis of pneumonias 1994
 11 S2 p. 183-184
2 p.
 artikel
36 Current radiotherapy perspectives for the treatment of limited small cell lung cancer 1994
 11 S2 p. 171-172
2 p.
 artikel
37 Current treatment of mesothelioma 1994
 11 S2 p. 248-
1 p.
 artikel
38 Current trends in the treatment of limited-disease small cell lung cancer 1994
 11 S2 p. 229-
1 p.
 artikel
39 Design and analyses of chemoprevention trials in patients with no evidence of disease(NED) 1994
 11 S2 p. 90-91
2 p.
 artikel
40 Detection of early lung cancer and preneoplastic lesions 1994
 11 S2 p. 161-162
2 p.
 artikel
41 DNA amplifications and losses in primary lung cancer detected by comparative genomic hybridization (CGH) Nakamura, H.
 1994
 11 S2 p. 157-158
2 p.
 artikel
42 Docetaxel (Taxotere®): A hemisynthetic taxoid active in lung cancer 1994
 11 S2 p. 78-79
2 p.
 artikel
43 Dose-escalation in non-small cell lung cancer using 3-dimensional radiation treatment planning 1994
 11 S2 p. 60-61
2 p.
 artikel
44 Dose esclations for non small cell lung cancers 1994
 11 S2 p. 62-63
2 p.
 artikel
45 Dose intensive combined modality therapy for small cell lung cancer 1994
 11 S2 p. 136-137
2 p.
 artikel
46 Dose, volume, and fractionation issues in thoracic irradiation of small cell lung cancer 1994
 11 S2 p. 173-174
2 p.
 artikel
47 Early intensification chemotherapy with etoposide (VP16), ifosfamide, carboplatinum and epirubicin with peripheral blood stem cell transplantation in patients with small-cell lung cancer (SCLC) 1994
 11 S2 p. 241-
1 p.
 artikel
48 Efficacy of CT-MR imaging in lung cancer staging 1994
 11 S2 p. 84-85
2 p.
 artikel
49 EGF receptor blockade with monoclonal antibodies 1994
 11 S2 p. 209-210
2 p.
 artikel
50 Endocrine cells in normal and hypoxic lung 1994
 11 S2 p. 193-194
2 p.
 artikel
51 Epidemiology of smoking and lung cancer: A historical perspective 1994
 11 S2 p. 1-
1 p.
 artikel
52 Extensive disease small cell lung cancer the thrill of victory; the agony of defeat Aisner, Joseph
 1994
 11 S2 p. 233-
1 p.
 artikel
53 Fractionation and dose issues in non-small cell lung cancer (NSCLC): Revising dose and volume standards, and re-establishing safety and efficacy parameters with three-dimensional (3-D) treatment planning tools Turrisi III, Andrew T.
 1994
 11 S2 p. 58-59
2 p.
 artikel
54 Fractionation and volume as factors in radiation injury in the lung 1994
 11 S2 p. 114-115
2 p.
 artikel
55 Fractionation in accelerated treatment of lung cancer 1994
 11 S2 p. 53-55
3 p.
 artikel
56 Future directions in the management of small cell lung cancer Johnson, David H.
 1994
 11 S2 p. 237-238
2 p.
 artikel
57 G-CSF and GM-CSF: Clinical issues in lung cancer management Lieschke, Graham J.
 1994
 11 S2 p. 187-188
2 p.
 artikel
58 Gemcitabine combination therapy for non-small cell lung cancer 1994
 11 S2 p. 26-27
2 p.
 artikel
59 Gene dysfunctions in rodent lung tumors 1994
 11 S2 p. 128-129
2 p.
 artikel
60 Gene replacement strategies for the prevention and therapy of lung cancer 1994
 11 S2 p. 66-67
2 p.
 artikel
61 Genetic changes in premalignancy 1994
 11 S2 p. 20-
1 p.
 artikel
62 Genetic changes in premalignancy for cancer detection 1994
 11 S2 p. 21-22
2 p.
 artikel
63 G2/M and metaphase/anaphase checkpoints in the cell cycle 1994
 11 S2 p. 6-7
2 p.
 artikel
64 Growth factors for small cell lung carcinoma 1994
 11 S2 p. 64-65
2 p.
 artikel
65 Histologic discriminants of biologic behavior in lung cancer 1994
 11 S2 p. 100-101
2 p.
 artikel
66 Ifosfamide, doxorubicin, vincristine and etoposide in SCLC 1994
 11 S2 p. 241-
1 p.
 artikel
67 Immunocytochemistry of neoplastic and preneoplastic respiratory epithelium 1994
 11 S2 p. 18-19
2 p.
 artikel
68 Immunotherapy of sepsis 1994
 11 S2 p. 191-192
2 p.
 artikel
69 Inactivation of the Rb gene in human cancer 1994
 11 S2 p. 8-9
2 p.
 artikel
70 Induction chemotherapy by ifosfamide, etoposide and anthracycline for small cell lung cancer — experience within the European lung cancer working party 1994
 11 S2 p. 241-
1 p.
 artikel
71 Infections in patients with lung cancer 1994
 11 S2 p. 185-186
2 p.
 artikel
72 Is there a place for brachytherapy in the management of lung cancer? 1994
 11 S2 p. 221-222
2 p.
 artikel
73 Late intensification with cisplatin/high-dose etoposide (HDLI) after induction chemotherapy in locally advanced small cell lung cancer (SCLC) 1994
 11 S2 p. 241-
1 p.
 artikel
74 Lung cancer: Acute and neuropathic pain 1994
 11 S2 p. 258-259
2 p.
 artikel
75 Lung cancer in Japan and lasers in the treatment of lung cancer 1994
 11 S2 p. 225-226
2 p.
 artikel
76 Lung cancer quality of life: A two-part symposium 1994
 11 S2 p. 239-240
2 p.
 artikel
77 Measuring quality of life in patients with lung cancer 1994
 11 S2 p. 70-71
2 p.
 artikel
78 Mechanisms and modifiers of radiation pneumotoxicity 1994
 11 S2 p. 116-117
2 p.
 artikel
79 Molecular changes preceding the onset of invasive lung cancers 1994
 11 S2 p. 16-17
2 p.
 artikel
80 Molecular epidemiology of lung cancer: carcinogen metabolites and adducts as biomarkers 1994
 11 S2 p. 124-125
2 p.
 artikel
81 Molecular genetic changes in the pathogenesis of lung cancer Minna, John D.
 1994
 11 S2 p. 256-257
2 p.
 artikel
82 Molecular mechanisms of drug resistance of lung cancer 1994
 11 S2 p. 205-206
2 p.
 artikel
83 Mucin-associated oligosaccharides as prognostic markers in squamous cell lung cancer 1994
 11 S2 p. 122-123
2 p.
 artikel
84 Multidrug resistance in lung cancer 1994
 11 S2 p. 203-204
2 p.
 artikel
85 Navelbine: The European experience in non small cell lung carcinoma (NSCLC) Chevalier, Thierry Le
 1994
 11 S2 p. 72-73
2 p.
 artikel
86 Navelbine® (Vinorelbine) in Non-Small Cell Lung Cancer (NSCLC) 1994
 11 S2 p. 74-75
2 p.
 artikel
87 Neoadjuvant (induction) therapy for treatment of non-small cell lung cancer 1994
 11 S2 p. 244-
1 p.
 artikel
88 Neuroendocrine neoplasms of the bronchopulmonary tract 1994
 11 S2 p. 199-200
2 p.
 artikel
89 New agents in the treatment of non-small cell lung cancer 1994
 11 S2 p. 249-
1 p.
 artikel
90 New Drugs for treating small cell lung cancer Ettinger, David S.
 1994
 11 S2 p. 236-
1 p.
 artikel
91 Oral therapy for small cell lung cancer 1994
 11 S2 p. 231-
1 p.
 artikel
92 Paclitaxel and cisplatin in advanced non-small cell lung cancer 1994
 11 S2 p. 247-
1 p.
 artikel
93 Paclitaxel in the treatment of lung cancer 1994
 11 S2 p. 76-77
2 p.
 artikel
94 Phase II study of topotecan in extensive stage small cell lung cancer 1994
 11 S2 p. 32-33
2 p.
 artikel
95 Phase II study with paclitaxel in advanced inoperable non-small cell lung cancer (NSCLC)—The European experience Gatzemeier, U.
 1994
 11 S2 p. 246-
1 p.
 artikel
96 Photodynamic therapy of early bronchogenic carcinoma 1994
 11 S2 p. 223-224
2 p.
 artikel
97 Potential diagnostic, prognostic, and therapeutic implications of mutations in the p53 tumor suppressor gene in lung cancer Carbone, David P.
 1994
 11 S2 p. 151-152
2 p.
 artikel
98 Preliminary results from screening patients at high risk for lung cancer through diagnostic protocol combining sputum cytology and fluorescence bronchoscopy 1994
 11 S2 p. 163-164
2 p.
 artikel
99 Prevention-oriented applications of biomarkers to follow the process of lung carcinogenesis 1994
 11 S2 p. 130-131
2 p.
 artikel
100 Quality of life endpoints for cancer trials 1994
 11 S2 p. 23-
1 p.
 artikel
101 Quality of life issues in lung cancer treatment and research 1994
 11 S2 p. 68-69
2 p.
 artikel
102 Radiation injury of the lung 1994
 11 S2 p. 106-107
2 p.
 artikel
103 Radiation response in lung cancer and its possible modification 1994
 11 S2 p. 108-109
2 p.
 artikel
104 Radiation sensitization of human lung cancer cells Mitchell, James B.
 1994
 11 S2 p. 110-111
2 p.
 artikel
105 Randomized study of etoposide or etoposide phosphate plus cisplatin for the treatment of small cell lung cancer 1994
 11 S2 p. 235-
1 p.
 artikel
106 Randomized trials on prophylactic cranial irradiation for patients with small cell lung cancer in complete remission 1994
 11 S2 p. 177-178
2 p.
 artikel
107 Report of the Third International Workshop on Lung Tumor and Differentiation antigens 1994
 11 S2 p. 118-119
2 p.
 artikel
108 Resection for peripheral higher stage lung tumor 1994
 11 S2 p. 37-38
2 p.
 artikel
109 Results of the euroscan trial 1994
 11 S2 p. 94-95
2 p.
 artikel
110 Retinoid chemoprevention of lung cancer 1994
 11 S2 p. 92-93
2 p.
 artikel
111 Significance of peripheral airway cell differentiation in lung carcinogenesis 1994
 11 S2 p. 102-103
2 p.
 artikel
112 Single agent therapy with gemcitabine in lung cancer — A review 1994
 11 S2 p. 28-29
2 p.
 artikel
113 Small cell lung cancer and the use of interleukin-3 1994
 11 S2 p. 189-190
2 p.
 artikel
114 Sputum cytology for the effective screening of early lung cancer 1994
 11 S2 p. 165-166
2 p.
 artikel
115 Superradical operation for lung cancer-bilateral mediastinal dissection (BMD) with or without cervical dissection (CD) 1994
 11 S2 p. 41-42
2 p.
 artikel
116 Surgery in small cell lung cancer 1994
 11 S2 p. 181-182
2 p.
 artikel
117 Surgical options for patients with mediastinal node involvement 1994
 11 S2 p. 43-44
2 p.
 artikel
118 Surgical treatment in locally advanced lung cancer 1994
 11 S2 p. 144-145
2 p.
 artikel
119 Surgical treatment of malignant mesothelioma 1994
 11 S2 p. 215-216
2 p.
 artikel
120 Surgical treatment of small cell lung cancer 1994
 11 S2 p. 228-
1 p.
 artikel
121 Taxoids in lung cancer Bishop, James F.
 1994
 11 S2 p. 250-251
2 p.
 artikel
122 The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy 1994
 11 S2 p. 252-253
2 p.
 artikel
123 The alpha-tocopherol, beta-carotene lung cancer prevention study 1994
 11 S2 p. 88-89
2 p.
 artikel
124 The biology of lung cancer 1994
 11 S2 p. 243-
1 p.
 artikel
125 The clinical implication of neuroendocrine markers in non-small cell lung cancer 1994
 11 S2 p. 201-202
2 p.
 artikel
126 The clinical significance of ras oncogene mutations in non-small cell lung cancer 1994
 11 S2 p. 155-156
2 p.
 artikel
127 The clinical status of topotecan (TPT), a novel inhibitor of topoisomerase 1994
 11 S2 p. 34-
1 p.
 artikel
128 The pathology of malignant mesothelioma 1994
 11 S2 p. 213-214
2 p.
 artikel
129 The place of ifosfamide in chemotherapy of small cell lung cancer (SCLC): The ECOG experience and a selected literature update 1994
 11 S2 p. 242-
1 p.
 artikel
130 The p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis 1994
 11 S2 p. 126-127
2 p.
 artikel
131 There is a role for chest x-rays for early lung cancer detection: A reappraisal of four randomized controlled trials on lung cancer screening 1994
 11 S2 p. 80-81
2 p.
 artikel
132 The role of limited resection in the treatment of early stage lung cancer 1994
 11 S2 p. 35-36
2 p.
 artikel
133 The role of prophylactic cranial irradiation in the treatment of small cell lung cancer (SCLC) 1994
 11 S2 p. 232-
1 p.
 artikel
134 The tobacco industry's manipulation of nicotine: Root cause of the modern lung cancer epidemic 1994
 11 S2 p. 2-3
2 p.
 artikel
135 Thoracoscopic lobectomy with mediastinal lymph node dissection McKenna Jr, Robert J
 1994
 11 S2 p. 134-135
2 p.
 artikel
136 Title: 3D radiotherapy: Its potential in treatment of lung cancer 1994
 11 S2 p. 56-57
2 p.
 artikel
137 Tobacco control worldwide 1994
 11 S2 p. 4-5
2 p.
 artikel
138 Tracheal sleeve pneumonectomy for lung cancer. A report of 51 cases 1994
 11 S2 p. 39-40
2 p.
 artikel
139 Treatment of relapsed small cell lung cancer 1994
 11 S2 p. 142-143
2 p.
 artikel
140 Treatment of the elderly small cell lung cancer patient 1994
 11 S2 p. 230-
1 p.
 artikel
141 Tumor suppressor loci from the short arm of chromosome 3 1994
 11 S2 p. 153-154
2 p.
 artikel
142 Ultrasound-assisted fiberoptic bronchoscopy utilizing miniature transducer catheters for the diagnosis of peripheral and central pulmonary masses 1994
 11 S2 p. 169-170
2 p.
 artikel
143 Video-assisted thoracoscopy for staging of lung cancer 1994
 11 S2 p. 132-133
2 p.
 artikel
144 Weekly chemotherapy for small cell lung cancer 1994
 11 S2 p. 138-139
2 p.
 artikel
                             144 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland